Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Jennifer Lister / Clinical Research Coordinator / UHN
CONTACT
Lead
ToLymph Inc.
With
PRIMARY OBJECTIVES: 1\. To evaluate the safety and tolerability of SMS001 in Non-Small Cell Lung Cancer (NSCLC) patients undergoing cancer surgery. SECONDARY OBJECTIVES: 1. To evaluate tumor recurrence at 12-month follow-up in NSCLC lung cancer patients treated at a predefined dose. 2. To evaluate disease free survival (DFS) for patients treated with SMS001 at the end of study.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted